We are live on ! Find out more
EDIT icon

Editas Medicine
EDIT

239 hedge funds and large institutions have $1.55B invested in Editas Medicine in 2020 Q3 according to their latest regulatory filings, with 44 funds opening new positions, 84 increasing their positions, 58 reducing their positions, and 43 closing their positions.

New
Increased
Maintained
Reduced
Closed

132% more call options, than puts

Call options by funds: $33.3M | Put options by funds: $14.3M

45% more repeat investments, than reductions

Existing positions increased: 84 | Existing positions reduced: 58

2% more first-time investments, than exits

New positions opened: 44 | Existing positions closed: 43

0% more funds holding

Funds holding: 238 → 239 (+1)

0.24% less ownership

Funds ownership: 88.82% → 88.57% (-0.24%)

4% less capital invested

Capital invested by funds: $1.61B → $1.55B (-$61M)

Holders
239
Holders Change
+1
Holders Change %
+0.42%
% of All Funds
4.82%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
44
Increased
84
Reduced
58
Closed
43
Calls
$33.3M
Puts
$14.3M
Net Calls
+$19M
Net Calls Change
-$15.2M

Top Buyers

Rank Fund Capital Flow
1
AIM
ARK Investment Management
Florida
+$102M
2
BlackRock
BlackRock
New York
+$16.6M
3
Goldman Sachs
Goldman Sachs
New York
+$7.05M
4
SOMRS
State of Michigan Retirement System
Michigan
+$6.39M
5
N
Nuveen
North Carolina
+$5.63M

Top Sellers

Rank Fund Capital Flow
1
CCM
CAAS Capital Management
New York
-$41.3M
2
APM
Avidity Partners Management
Texas
-$17.7M
3
Viking Global Investors
Viking Global Investors
Connecticut
-$12.2M
4
D.E. Shaw & Co
D.E. Shaw & Co
New York
-$9.04M
5
State Street
State Street
Massachusetts
-$5.64M
Name Holding Trade Value Shares
Change 		Change in
Stake
AA
176
Ancora Advisors
Ohio
$22K – – –
WIM
177
Westside Investment Management
California
$19.7K -$3.26K -100 -3%
BG
178
Bollard Group
Massachusetts
$19K – – –
TIM
179
Tortoise Investment Management
New York
$19K – – –
SFS
180
Sowell Financial Services
Arkansas
$19K +$18.3K +561 +484%
WAM
181
Wolverine Asset Management
Illinois
$19K +$22.4K +687 New
NFSG
182
Newbridge Financial Services Group
Florida
$18K +$20.7K +636 New
AF
183
Allworth Financial
California
$17K +$19.5K +600 New
Rockefeller Capital Management
184
Rockefeller Capital Management
New York
$15K +$18.4K +564 New
ASN
185
Advisory Services Network
Georgia
$14K +$15.9K +489 New
FHC
186
First Horizon Corporation
Tennessee
$14K +$16.3K +500 New
ICM
187
Islay Capital Management
Texas
$14K +$16.3K +500 New
PCM
188
Penserra Capital Management
California
$14K +$17.3K +532 New
ME
189
McIlrath & Eck
Washington
$13K – – –
WT
190
Washington Trust
Rhode Island
$12K – – –
CG
191
Cutler Group
California
$11K -$6.19K -190 -32%
MPWT
192
MassMutual Private Wealth & Trust
Connecticut
$11K -$1.37K -42 -10%
CFN
193
Cordasco Financial Network
Florida
$11K – – –
HNB
194
Huntington National Bank
Ohio
$11K – – –
Daiwa Securities Group
195
Daiwa Securities Group
Japan
$9K – – –
GWS
196
Glassman Wealth Services
Virginia
$9K – – –
RG
197
Retirement Group
California
$9K +$10.6K +325 New
CTC
198
Central Trust Company
Missouri
$8K -$4.23K -130 -30%
CFGS
199
Concourse Financial Group Securities
Alabama
$8K – – –
WT
200
Whittier Trust
California
$8K – – –
6 7
8
9 10

EDIT Hedge Fund Activity: Q3 2020 in Review

239 of the 4,956 institutional investors tracked by Wall St. Rank reported a position in Editas Medicine (EDIT) for Q3 2020, worth a combined $1.55B — down 3.8% from $1.61B a quarter earlier.

Buyers outnumbered sellers: 44 funds opened new EDIT positions and 43 closed out — a net gain of 1 holder — while 84 added to existing stakes and 58 trimmed.

The largest buyer was ARK Investment Management, adding an estimated $102M. The largest seller was CAAS Capital Management, exiting entirely with an estimated $41.3M sold.

  • 239 institutional investors held Editas Medicine (EDIT) as of Q3 2020, up from 238 in Q2 2020.
  • Funds reported $1.55B of Editas Medicine stock for Q3 2020, down 3.8% quarter-over-quarter.
  • 44 funds opened new Editas Medicine positions in Q3 2020 and 43 closed out, a net change of +1 holder.
  • The largest Editas Medicine buyer in Q3 2020 was ARK Investment Management, an estimated $102M added.
  • The largest Editas Medicine seller in Q3 2020 was CAAS Capital Management, an estimated $41.3M sold.

Based on aggregated 13F filings for Q3 2020.